• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆小管细胞肝癌:一种看似良性的恶性肝肿瘤,类似于胆小管反应。

Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.

机构信息

Department of Pathology, Cliniques Universitaires Saint Luc, Brussels, Belgium.

出版信息

Semin Liver Dis. 2011 Feb;31(1):104-10. doi: 10.1055/s-0031-1272838. Epub 2011 Feb 22.

DOI:10.1055/s-0031-1272838
PMID:21344355
Abstract

The authors present an interesting case of a 60-year-old man who underwent right hepatectomy for a diagnosis of hepatocellular carcinoma (HCC) on a background of noncirrhotic chronic hepatitis C. Pathologic examination confirmed the presence of HCC near the porta hepatis, which invaded the right portal vein branch. In addition, a well-demarcated 13.5 × 7.8 × 4.0 cm yellow and firm area upstream of the HCC was noted. This yellow area corresponded to a tumoral ductular proliferation, which cytologically was extremely bland, but invaded portal tracts and the adjacent liver parenchyma. This tumoral proliferation mimicked ductular reaction, except that it had more anastomosing structures and was associated with abundant hyalinized fibrotic stroma. Cytologically, the tumor cells had round to oval nuclei with fine chromatin, indistinct nucleoli, and scant cytoplasm. They exhibited immunohistochemical features of hepatic progenitor cells, i.e., expressing CK7, CK19, and N-CAM; and their malignancy was supported by the p53 and Ki67 immunoreactivity. The authors concluded that the patient had cholangiolocellular carcinoma with an aggressive hepatocellular carcinoma component. Cholangiolocellular carcinoma has been reported to be associated with chronic hepatitis C viral infection and to derive from hepatic progenitor cells, which explains why hepatocellular carcinoma and/or cholangiocarcinoma component may be present.

摘要

作者报告了一例有趣的病例,一名 60 岁男性因非肝硬化性慢性丙型肝炎背景下的肝细胞癌(HCC)而行右肝切除术。病理检查证实 HCC 位于肝门附近,侵犯右门静脉分支。此外,还注意到 HCC 上游有一个界限清楚的 13.5×7.8×4.0cm 的黄色和坚实区域。这个黄色区域对应于肿瘤性小管增生,其细胞学上极其温和,但侵犯门脉区和相邻的肝实质。这种肿瘤性增生类似于胆管反应,只是它具有更多的吻合结构,并伴有丰富的玻璃样纤维化基质。细胞学上,肿瘤细胞具有圆形到椭圆形核,染色质细,核仁不明显,细胞质稀少。它们表现出肝祖细胞的免疫组织化学特征,即表达 CK7、CK19 和 N-CAM;p53 和 Ki67 免疫反应支持其恶性程度。作者得出结论,患者患有具有侵袭性肝细胞癌成分的胆管细胞癌。胆管细胞癌已被报道与慢性丙型肝炎病毒感染有关,并源自肝祖细胞,这解释了为什么可能存在肝细胞癌和/或胆管癌成分。

相似文献

1
Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.胆小管细胞肝癌:一种看似良性的恶性肝肿瘤,类似于胆小管反应。
Semin Liver Dis. 2011 Feb;31(1):104-10. doi: 10.1055/s-0031-1272838. Epub 2011 Feb 22.
2
Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.肝细胞癌和胆管癌混合型的手术治疗病例。
Hepatogastroenterology. 2002 Jul-Aug;49(46):1083-6.
3
[Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].[用于肝细胞癌与肝内胆管癌鉴别诊断的免疫组化标志物评估]
Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):702-5.
4
Synchronously resected double primary hepatic cancers - hepatocellular carcinoma and cholangiolocellular carcinoma.同步切除的双原发性肝癌——肝细胞癌和胆管细胞癌。
J Hepatobiliary Pancreat Surg. 2006;13(6):571-6. doi: 10.1007/s00534-006-1118-0. Epub 2006 Nov 30.
5
Combined hepatocellular and cholangiocellular carcinoma.肝细胞胆管细胞混合型癌
Radiat Med. 1997 Jul-Aug;15(4):243-6.
6
Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.免疫组化染色多梳蛋白组蛋白 EZH2 和衰老标志物 p16INK4a 可能有助于鉴别胆毛细胆管细胞癌与胆管反应和胆管腺瘤。
Am J Surg Pathol. 2014 Mar;38(3):364-9. doi: 10.1097/PAS.0000000000000125.
7
Intrahepatic cholangiocarcinoma: new insights in pathology.肝内胆管细胞癌:病理学新见解。
Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22.
8
A resected case of a small hepatocellular carcinoma developing within the bile duct.一例发生于胆管内的小肝细胞癌切除病例。
J Hepatobiliary Pancreat Surg. 2004;11(3):193-6. doi: 10.1007/s00534-003-0862-7.
9
Hepatic recurrence of cholangiolocellular carcinoma: report of a case.肝内胆管细胞癌肝转移:1例报告
Hepatogastroenterology. 1996 Jul-Aug;43(10):1046-50.
10
The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.肝细胞石蜡1抗体在免疫组织学上鉴别肝细胞癌与胆管癌及转移癌中的应用。
Malays J Pathol. 2006 Dec;28(2):87-92.

引用本文的文献

1
Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.肝脏疾病的当前及新出现的分子标志物:致病机制视角
Gene Expr. 2022;21(1):9-19. doi: 10.14218/gejlr.2022.00010. Epub 2022 Sep 28.
2
Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: A single institution retrospective study.胆管癌的临床病理特征及肿瘤异质性对预后的影响:一项单机构回顾性研究。
Oncol Lett. 2024 Mar 15;27(5):213. doi: 10.3892/ol.2024.14346. eCollection 2024 May.
3
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.
日本肝癌研究组肝内胆管癌临床实践指南
Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul.
4
Cholangiocarcinoma.胆管癌。
Pathologica. 2021 Jun;113(3):158-169. doi: 10.32074/1591-951X-252.
5
Cholangiocarcinoma: novel therapeutic targets.胆管癌:新的治疗靶点。
Expert Opin Ther Targets. 2020 Apr;24(4):345-357. doi: 10.1080/14728222.2020.1733528. Epub 2020 Feb 26.
6
Neuroendocrine Changes in Cholangiocarcinoma Growth.神经内分泌变化在胆管癌生长中的作用。
Cells. 2020 Feb 13;9(2):436. doi: 10.3390/cells9020436.
7
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.双表型(肝胆型)原发性肝癌:进展中的工作。
Hepat Oncol. 2015 Jul;2(3):255-273. doi: 10.2217/hep.15.8. Epub 2015 Jul 28.
8
Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.谷胱甘肽S-转移酶A3基因敲除小鼠肝脏损伤、卵圆细胞增殖及胆管癌发生的特征分析
Carcinogenesis. 2017 Jul 1;38(7):717-727. doi: 10.1093/carcin/bgx048.
9
Pathology of intrahepatic cholangiocarcinoma.肝内胆管癌的病理学
Hepatobiliary Surg Nutr. 2017 Feb;6(1):22-34. doi: 10.21037/hbsn.2016.11.04.
10
Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.增殖指数有助于鉴别良性胆管病变和肝内胆管癌。
Hum Pathol. 2016 Nov;57:61-67. doi: 10.1016/j.humpath.2016.06.019. Epub 2016 Jul 7.